Abstract:Acute liver injury is a rapidly deteriorating clinical condition with markedly high morbidity and mortality. Oleoylethanolamide (OEA) is an endogenous lipid messenger with multiple bioactivities, and has therapeutic effects on various liver diseases. However, effects of OEA on acute liver injury remains unknown. In this study, effects and mechanisms of OEA in lipopolysaccharide (LPS)/d-galactosamine (D-Gal)-induced acute liver injury in mice were investigated. We found that OEA treatment significantly attenuated LPS/D-Gal-induced hepatocytes damage, reduced liver index (liver weight/body weight), decreased plasma alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) levels. Moreover, mechanism study suggested that OEA pretreatment significantly reduced hepatic MDA levels, increased Superoxide dismutase (SOD) and Glutathione peroxidase (GSH-PX) activities via up-regulate Nrf-2 and HO-1 expression to exert anti-oxidation activity. Additionally, OEA markedly reduced the expression levels of Bax, Bcl-2 and cleaved caspase-3 to suppress hepatocyte apoptosis. Meanwhile, OEA remarkedly reduced the number of activated intrahepatic macrophages, and alleviated the mRNA expression of pro-inflammatory factors, including TNF-alpha, IL-6, MCP1 and RANTES. Furthermore, OEA obviously reduced the expression of IL-1 beta in liver and plasma through inhibit protein levels of NLRP3 and caspase-1, which indicated that OEA could suppress NLRP3 inflammasome pathway. We further determined the protein expression of PPAR-alpha in liver and found that OEA significantly increase hepatic PPAR-alpha expression. In addition, HO-1 inhibitor ZnPP blocked the therapeutic effects of OEA on LPS/D-Gal-induced liver damage and oxidative stress, suggesting crucial role of Nrf-2/HO-1 pathway in the protective effects of OEA in acute liver injury. Together, these findings demonstrated that OEA protect against the LPS/D-Gal-induced acute liver injury in mice through the inhibition of apoptosis, oxidative stress and inflammation, and its mechanisms might be associated with the Nrf-2/HO-1 and NLRP3 inflammasome signaling pathways.

Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice

The Protective Effect of Oleoylethanolamide on Acute Focal Cerebral Ischemia/reperfusion Injury in Mice and Its Mechanism

Orally Administered Oleoylethanolamide Protects Mice from Focal Cerebral Ischemic Injury by Activating Peroxisome Proliferator-Activated Receptor Α

Oleoylethanolamide Attenuates Apoptosis by Inhibiting the TLR4/NF-κB and ERK1/2 Signaling Pathways in Mice with Acute Ischemic Stroke

Oleoylethanolamide exerts anti-inflammatory effects on LPS-induced THP-1 cells by enhancing PPARα signaling and inhibiting the NF-κB and ERK1/2/AP-1/STAT3 pathways

Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells

Oleoylethanolamide attenuates acute-to-chronic kidney injury: in vivo and in vitro evidence of PPAR-α involvement

The Hypolipidemic and Liver Protective Effect of Oleoylethanolamide in Hyperlipidemic Rats

Oleoylethanolamide Protects against Acute Ischemic Stroke by Promoting PPARα-Mediated Microglia/Macrophage M2 Polarization

Atheroprotective Effect of Oleoylethanolamide (OEA) Targeting Oxidized LDL.

Inhibitory Effects of Oleoylethanolamide (OEA) on H₂O₂-induced Human Umbilical Vein Endothelial Cell (HUVEC) Injury and Apolipoprotein E Knockout (Apoe-/-) Atherosclerotic Mice.

Oleoylethanolamide inhibits glial activation via moudulating PPARα and promotes motor function recovery after brain ischemia.

Protective Effect of Oleoylethanolamide on Focal Cerebral Ischemia in Mice

Protective effects and related mechanism of olive leaf methanolic extract against acute liver injury in mice induced by D-galactosamine/lipopolysaccharide

Effect of Oleoylethanolamide on Diet-Induced Nonalcoholic Fatty Liver in Rats

Oleic Acid Protects Against Hepatic Ischemia and Reperfusion Injury in Mice by Inhibiting AKT/mTOR Pathways.

Chronic oleoylethanolamide treatment improves spatial cognitive deficits through enhancing hippocampal neurogenesis after transient focal cerebral ischemia.

The Effect of Oleoylethanolamide on the Expression of Cytokines in Lipopolysaccharide Induced THP-1cells

Oleoylethanolamide facilitates PPARa and TFEB signaling and attenuates Ab pathology in a mouse model of Alzheimer's disease.

Oleoylethanolamide facilitates PPARα and TFEB signaling and attenuates Aβ pathology in a mouse model of Alzheimer's disease

Oleoylethanolamide ameliorates motor dysfunction through PPARα‐mediates oligodendrocyte differentiation and white matter integrity after ischemic stroke